Researchers are developing a cancer metastasis-on-chip assay for high-throughput drug screening, utilizing organ-on-a-chip technology. This technology is being applied in various aspects of cancer therapy, including the detection of metastatic cells and the screening of tumor organoids. The development of lab-on-a-chip systems and tumor-on-a-chip models is also being explored for personalized therapeutics and cancer precision medicine.